Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers.
Ogony J, Hoskin TL, Stallings-Mann M, Winham S, Brahmbhatt R, Arshad MA, Kannan N, Peña A, Allers T, Brown A, Sherman ME, Visscher DW, Knutson KL, Radisky DC, Degnim AC. Ogony J, et al. Among authors: stallings mann m. Breast Cancer Res Treat. 2023 Jan;197(2):277-285. doi: 10.1007/s10549-022-06786-y. Epub 2022 Nov 16. Breast Cancer Res Treat. 2023. PMID: 36380012 Free PMC article.
Immune cell quantitation in normal breast tissue lobules with and without lobulitis.
Degnim AC, Brahmbhatt RD, Radisky DC, Hoskin TL, Stallings-Mann M, Laudenschlager M, Mansfield A, Frost MH, Murphy L, Knutson K, Visscher DW. Degnim AC, et al. Breast Cancer Res Treat. 2014 Apr;144(3):539-49. doi: 10.1007/s10549-014-2896-8. Epub 2014 Mar 5. Breast Cancer Res Treat. 2014. PMID: 24596048 Free PMC article.
Ki-67 expression in sclerosing adenosis and adjacent normal breast terminal ductal lobular units: a nested case-control study from the Mayo Benign Breast Disease Cohort.
Nassar A, Hoskin TL, Stallings-Mann ML, Degnim AC, Radisky DC, Frost MH, Vierkant RA, Hartmann LC, Visscher DW. Nassar A, et al. Breast Cancer Res Treat. 2015 May;151(1):89-97. doi: 10.1007/s10549-015-3370-y. Epub 2015 Apr 12. Breast Cancer Res Treat. 2015. PMID: 25863475 Free PMC article.
Gene signature model for breast cancer risk prediction for women with sclerosing adenosis.
Degnim AC, Nassar A, Stallings-Mann M, Keith Anderson S, Oberg AL, Vierkant RA, Frank RD, Wang C, Winham SJ, Frost MH, Hartmann LC, Visscher DW, Radisky DC. Degnim AC, et al. Breast Cancer Res Treat. 2015 Aug;152(3):687-94. doi: 10.1007/s10549-015-3513-1. Epub 2015 Jul 23. Breast Cancer Res Treat. 2015. PMID: 26202055 Free PMC article.
Natural history of age-related lobular involution and impact on breast cancer risk.
Radisky DC, Visscher DW, Frank RD, Vierkant RA, Winham S, Stallings-Mann M, Hoskin TL, Nassar A, Vachon CM, Denison LA, Hartmann LC, Frost MH, Degnim AC. Radisky DC, et al. Breast Cancer Res Treat. 2016 Feb;155(3):423-30. doi: 10.1007/s10549-016-3691-5. Epub 2016 Feb 4. Breast Cancer Res Treat. 2016. PMID: 26846985 Free PMC article.
Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study.
Figueroa JD, Pfeiffer RM, Brinton LA, Palakal MM, Degnim AC, Radisky D, Hartmann LC, Frost MH, Stallings Mann ML, Papathomas D, Gierach GL, Hewitt SM, Duggan MA, Visscher D, Sherman ME. Figueroa JD, et al. Breast Cancer Res Treat. 2016 Aug;159(1):163-72. doi: 10.1007/s10549-016-3908-7. Epub 2016 Aug 3. Breast Cancer Res Treat. 2016. PMID: 27488681 Free PMC article.
Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development.
Degnim AC, Hoskin TL, Arshad M, Frost MH, Winham SJ, Brahmbhatt RA, Pena A, Carter JM, Stallings-Mann ML, Murphy LM, Miller EE, Denison LA, Vachon CM, Knutson KL, Radisky DC, Visscher DW. Degnim AC, et al. Clin Cancer Res. 2017 Jul 15;23(14):3945-3952. doi: 10.1158/1078-0432.CCR-16-2026. Epub 2017 Jan 26. Clin Cancer Res. 2017. PMID: 28126725
Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution.
Stallings-Mann ML, Heinzen EP, Vierkant RA, Winham SJ, Hoskin TL, Denison LA, Nassar A, Hartmann LC, Visscher DW, Frost MH, Sherman ME, Degnim AC, Radisky DC. Stallings-Mann ML, et al. Breast Cancer Res Treat. 2017 Nov;166(1):133-143. doi: 10.1007/s10549-017-4413-3. Epub 2017 Jul 27. Breast Cancer Res Treat. 2017. PMID: 28752190 Free PMC article.
NanoString-based breast cancer risk prediction for women with sclerosing adenosis.
Winham SJ, Mehner C, Heinzen EP, Broderick BT, Stallings-Mann M, Nassar A, Vierkant RA, Hoskin TL, Frank RD, Wang C, Denison LA, Vachon CM, Frost MH, Hartmann LC, Aubrey Thompson E, Sherman ME, Visscher DW, Degnim AC, Radisky DC. Winham SJ, et al. Breast Cancer Res Treat. 2017 Nov;166(2):641-650. doi: 10.1007/s10549-017-4441-z. Epub 2017 Aug 10. Breast Cancer Res Treat. 2017. PMID: 28798985 Free PMC article.
CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes.
Kerekes D, Visscher DW, Hoskin TL, Radisky DC, Brahmbhatt RD, Pena A, Frost MH, Arshad M, Stallings-Mann M, Winham SJ, Murphy L, Denison L, Carter JM, Knutson KL, Degnim AC. Kerekes D, et al. Breast Cancer Res Treat. 2018 Feb;167(3):649-658. doi: 10.1007/s10549-017-4558-0. Epub 2017 Nov 1. Breast Cancer Res Treat. 2018. PMID: 29090365 Free PMC article.
35 results